Clinical management of diazoxide-unresponsive congenital hyperinsulinism: A single-center experience-Reference-Cited by-同舟云学术

Clinical management of diazoxide-unresponsive congenital hyperinsulinism: A single-center experience

Published:2024 Issue:3 Volume:33 Page:187-194
ISSN:0918-5739
Container-title:Clinical Pediatric Endocrinology
language:en
Short-container-title:Clin Pediatr Endocrinol

Author:

Takasawa Kei¹,Iemura Ryosei¹,Orimoto Ryuta¹,Yamano Haruki¹,Kirino Shizuka¹,Adachi Eriko¹,Saito Yoko¹²,Yamamoto Kurara³,Matsuda Nozomi⁴,Takishima Shigeru⁴,Shuno Kumi⁵,Tajima Hanako⁵,Sugie Manabu¹,Mizuno Yuki⁶,Sutani Akito⁷,Okamoto Kentaro⁶,Masue Michiya⁸,Morio Tomohiro¹,Kashimada Kenichi¹

Affiliation:

1. Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan

2. Division of Medical Genetics, Kanagawa Children’s Medical Center, Yokohama, Japan

3. Department of Human Pathology, Tokyo Medical and Dental University, Tokyo, Japan

4. Department of Pediatrics, Soka Municipal Hospital, Saitama, Japan

5. Department of Pediatrics, Nippon Medical School, Tokyo, Japan

6. Department of Pediatric Surgery, Tokyo Medical and Dental University Hospital, Tokyo, Japan.

7. Department of Pediatrics, Kawaguchi Municipal Medical Center, Saitama, Japan

8. Department of Pediatrics, Central Japan International Medical Center, Gifu, Japan

Publisher

Japanese Society for Pediatric Endocrinology

Link

https://www.jstage.jst.go.jp/article/cpe/33/3/33_2024-0004/_pdf

Reference47 articles.

1. 1. Yorifuji, T, Horikawa, R, Hasegawa, T, Adachi, M, Soneda, S, Minagawa, M, et al. (on behalf of The Japanese Society for Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons). Clinical practice guidelines for congenital hyperinsulinism. Clin Pediatr Endocrinol 2017;26: 127–52.

2. 2. Yamada, Y, Kitayama, K, Oyachi, M, Higuchi, S, Kawakita, R, Kanamori, Y, et al. Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017-2018): Congenital hyperinsulinism, insulinoma, non-insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata’s disease). J Diabetes Investig 2020;11: 554–63.

3. 3. Chen, X, Feng, L, Yao, H, Yang, L, Qin, Y. Efficacy and safety of diazoxide for treating hyperinsulinemic hypoglycemia: A systematic review and meta-analysis. PLoS One 2021;16: e0246463.

4. 4. Snider, KE, Becker, S, Boyajian, L, Shyng, SL, MacMullen, C, Hughes, N, et al. Genotype and phenotype correlations in 417 children with congenital hyperinsulinism. J Clin Endocrinol Metab 2013;98: E355–63.

5. 5. Sakakibara, A, Hashimoto, Y, Kawakita, R, Hosokawa, Y, Nagahara, K, Hasegawa, Y, et al. Diagnosis of congenital hyperinsulinism: Biochemical profiles during hypoglycemia. Pediatr Diabetes 2018;19: 259–64.